Search PubMed⌕ Search

Biomedical subjects

M Dennis

Publications and source records attributed to M Dennis.

At least 181 records · Page 10Linked to original sources

Mathematical basis and generalization of the Loo-Riegelman method for the determination of in vivo drug absorption.

A general numerical deconvolution method is derived for the determination of in vivo drug input functions. The derivation is based on linear interpolation of observed drug concentrations and deconvolution of the resulting trapezoidal function. Derived in vivo input functions are discontinuous. A general expression for the cumulative drug input is also derived. The latter expression is a generalization of the Loo-Riegelman equations. This deconvolution method give similar results to the "point-area" deconvolution method when deriving in vivo drug input functions.

Intestinal Absorption↗

Hemispherectomy for Sturge-Weber syndrome.

Patients with Sturge-Weber disease who have the onset of seizures in infancy invariably face a progressively downhill course which leaves them severely hemiplegic, demented and usually institutionalized because of uncontrolled seizures. During the past 12 years, we have carried out 6 hemispherectomies in infants under 1 year of age who presented with seizures and Sturge-Weber disease. The results have been gratifying. Seizures have stopped, hemipareses have been minimal and intellectual development has been good.

Angiomatosis↗

Endoscopic laser treatment. II. Comparison of the efficacy of high and low power photocoagulation in control of severely bleeding experimental ulcers in dogs.

The coagulative efficacy of a "high power" argon laser which delivers 6.5 +/- 1.0 w was compared to that of a "low power" argon laser which delivers 1.0 +/- 0.1 w. The wave-guide angle of divergence was 8 degrees. For the high power laser, the distance between the wave-guide tip and the mucosa varied from 1.0 to 1.5 cm with a delivered power density range of 160 to 487 w per cm2. For the low power laser, the distance between the tip and mucosa varied from 0.7 to 1.3 cm with a power density of 35 to 146 w per cm2. Group A consisted of acute experiments in 6 heparinized dogs in which 51 standard-sized acute gastric ulcers extending into the submucosa were made at laparotomy via a large gastrotomy. Ulcer bleeding rates were quantified into three categories of severity. Within each category, ulcers were randomized to high power, low power, or untreated control. All 19 low power-treated ulcers and 16 untreated controls continued bleeding; 13 of 16 high power-treated ulcers stopped bleeding completely. Representative ulcers were examined histologically. Group B consisted of chronic experiments on 31 ulcers in 7 unheparinized dogs. These ulcers were either treated with high power or left as untreated controls. Dogs were killed and the ulcers were examined histologically at 7, 14, and 28 days. Only rarely did the laser injury penetrate into the muscularis externa. There were no perforations. By 14 days, all lesions were covered with normal surface epithelium. These data encourage further development of congruent to 7.0 w argon laser photocoagulation for eventual clinical use in man.

Animals↗

Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man.

[3H]-testosterone undecanoate ([3H]TU) was administered orally to 4 patients with a thoracic duct catheter after neck dissection surgery. Appearance of radioactivity in lymph, plasma and urine was measured at different times. Metabolites of TU in these fluids were investigated. Peak levels of radioactivity appeared simultaneously in lymph and plasma (2.5-5 h after administration) while the excretion in urine was highest approximately 2 h after the plasma and lymph peak. The main compounds appearing in the lymph were TU and 5alpha-dihydrotestosterone undecanoate (5alpha-DHTU), but 5beta-DHTU could not be detected. In plasma almost all metabolites were probably conjugated. During the first 24 h approximately 40% of the administered radioactivity was excreted in the urine. The total amount of radioactivity excreted in the urine during the first week was 45-48%. The predominant urinary metabolites were testosterone- and androsterone-glucuronide. The results indicate that TU is metabolized partly in the intestinal wall. The remaining TU and newly-formed 5alpha-DHTU, at least partly, are absorbed via the lymphatic system.

Administration, Oral↗